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Abstract
Background: Taiwan established a system of universal National Health Insurance (NHI) in March, 1995. Today, the
NHI covers more than 98% of Taiwan’s population and enrollees enjoy almost free access to healthcare with small
co-payment by most clinics and hospitals. Yet while this expansion of coverage will almost inevitably have
improved access to health care, however, it cannot be assumed that it will necessarily have improved the health of
the population. The aim of this study was to determine whether the introduction of National Health Insurance
(NHI) in Taiwan in 1995 was associated with a change in deaths from causes amenable to health care.
Methods: Identification of discontinuities in trends in mortality considered amenable to health care and all other
conditions (non-amenable mortality) using joinpoint regression analysis from 1981 to 2005.
Results: Deaths from amenable causes declined between 1981 and 1993 but slowed between 1993 and 1996.
Once NHI was implemented, the decline accelerated significantly, falling at 5.83% per year between 1996 and 1999.
In contrast, there was little change in non-amenable causes (0.64% per year between 1981 and 1999). The effect of
NHI was highest among the young and old, and lowest among those of working age, consistent with changes in
the pattern of coverage. NHI was associated with substantial reductions in deaths from circulatory disorders and,
for men, infections, whilst an earlier upward trend in female cancer deaths was reversed.
Conclusions: NHI was associated in a reduction in deaths considered amenable to health care; particularly among
those age groups least likely to have been insured previously.
Background
Taiwan established a system of universal National
Health Insurance (NHI) in March, 1995, replacing 13
occupational funds that had covered only about 60% of
the population (including military health services), lar-
gely covering the population at working age. Coverage
was 14%, 77%, and 57% for those aged under 20, 20-64
and 65 year and over respectively. Today, the NHI cov-
ers more than 98% of Taiwan’s 23 million population
and enrollees enjoy almost free access to healthcare,
except for a small co-payment, plus some registration
fees that, although not mandatory, are required by most
clinics and hospitals. Yet while this expansion of cover-
age will almost inevitably have improved access to
health care, given evidence of significant disparities in
utilization under the former system [1], it cannot be
assumed that it will necessarily have improved the
health of the population. Indeed, Levy and Meltzer [2]
and McWilliams [3] have drawn attention to the many
existing limitations of existing research linking expan-
sion of coverage to health improvement. In this paper
we take advantage of the opportunity provided by the
natural experiment of implementing NHI in Taiwan to
examine this issue.
Taiwan’s NHI scheme has been described previously
[4,5]. In brief, it is a universal single-payer social health
insurance system, based on a public-contract model,
offering comprehensive benefits. The main sources of
funds are an income-related premium (payroll taxes),
with employees, employers, and government all paying a
share of premiums. The share of the premiums paid by
the insured, by employers, and by government varies
according to employment status. For employees in public
or private enterprises, the shares are 30%, 60% and 10%
respectively. The high-income self-employed insured pay
* Correspondence: kennank@aol.com
3Division of Health Policy Research and Development, Institute of Population
Health Sciences, National Health Research Institutes, 35 Keyan Road, Zhunan,
Miaoli County 35053, Taiwan
Full list of author information is available at the end of the article
Lee et al. BMC Health Services Research 2010, 10:225
http://www.biomedcentral.com/1472-6963/10/225
© 2010 Lee et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
100% of the premium themselves. The government pays
100% of the premium for military personnel and the low-
income unemployed, and pays 40% of the premium for
the other unemployed. The amount collected by the NHI
in respect of each enrollee varies according to his or her
number of dependents, although dependents in excess of
three are effectively insured for free. These insurance
premiums are supplemented by smaller contributions
from co-payments, alcohol and tobacco taxes and lottery
revenues, and recompense from national environmental
pollution funds and automobile insurance. In 2008, total
national health expenditure was US$ 23.9 billion, or 6.4%
of GDP (exchange rate 33 NTD:1USD). Expenditure on
the NHI was US$12.8 billion, or 53.5% of national health
expenditure, which equated to 3.4% of gross domestic
product (GDP) [6], which was lower than in most OECD
countries [7].
Previous evaluations of Taiwan’s NHI have focused on
access and cost containment [8-10], with little research
on the impact of its introduction on population health.
One study found that the NHI had reduced rural-urban
disparities in the incidence of ruptured appendicitis [11].
Another found improved access to care by the elderly but
no measurable impact on their self-perceived health [12].
Yet another examined changing life expectancy [13], but
it failed to identify an overall association with the intro-
duction of NHI although the gap between the most and
least healthy townships did narrow significantly. How-
ever, as life expectancy captures the entire range of health
determinants [14], more specific analyses are needed.
In this paper we seek to identify any contribution of
health care using the concept of amenable mortality, or
“mortality amenable to health care”, applying methods
developed by Nolte and McKee [15]. These capture
causes of deaths that should not occur in presence of
timely and effective health care [16] and have been used
in other evaluations of health system performance
[17-19].
We hypothesized that, if the introduction of NHI had
an impact on population health, this should be reflected
by a discontinuity in the trend in amenable mortality
but not in non-amenable mortality. We also hypothe-
sized that the effect of NHI would be less apparent
among the working age population, who were more
likely to have been insured previously than non-working
age groups. With the advantage of comprehensive high
quality death registration data covering a population of
almost 23 million, our findings may be relevant to other
countries that have yet to establish universal health
insurance coverage.
Methods
We used joinpoint regression analysis [20] to identify
changes in mortality trends that might be associated with
implementation of NHI in Taiwan, distinguishing mortal-
ity from causes considered amenable to health care and
mortality from all other causes during 1981-2005.
Data
Mortality data were taken from the Death Registry Data-
base, maintained by the Taiwan Department of Health,
with population data from the Household Population
Registration System (HPRS) provided by the Ministry of
the Interior. These were used to calculate age, sex and
cause-specific mortality rates, coded using the ninth
revision of the International Classification of Diseases
and Deaths (ICD-9).
Amenable mortality
Causes of death considered amenable to health care are
those defined by Nolte and McKee [15,17]. They include
causes such as bacterial infections, treatable cancer, dia-
betes, cardiovascular and cerebrovascular disease, and
complications of common surgical procedures for
people under age 75.
We combined causes of deaths to calculate cause-spe-
cific amenable mortality rates. We also include ischemic
heart disease (IHD) but treat this cause separately as the
precise contribution of health care to reductions in
deaths from this condition remains unresolved [21,22].
Also, deaths from IHD tend to dominate analyses
because of their large numbers. For consistency with
other studies, we here present amenable deaths with
and without 50% IHD [17,19].
The number of deaths from causes other than amen-
able at ages 0-74 was 40,352 in 1981, rising to 55,141 in
2005 while the corresponding figures for amenable
causes (excluding IHD) fell, from 21,508 to 16,441, with
deaths from IHD rising from 1,643 to 3,338 in the same
period.
Measurement and analysis
To account for changes in population composition, we
calculated age-standardized mortality rates (ASMR)
using direct standardization to the 2000 WHO world
standard population. The ASMR is the sum of the pro-
duct of mortality rate in the ith age stratum (Mi) in a
given year in Taiwan and the proportion of population
of standard (WHO) population in the same age stratum
in the same year (StdPi) as follows: ASMR=∑i=1n[Mi×S-
tdPi] Analyses were undertaken for all ages 0-74 as well
as for three age groups, under 20, 20-64, and 65 years
and over. Trends in amenable and non-amenable mor-
tality are shown in Figure 1.
Statistical analyses
We used joinpoint regression analysis originally devel-
oped for use in cancer epidemiology, to identify points
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of significant inflection in trends. The analysis starts
with minimum number of inflections (joinpoints), and
tests whether one or more additional joinpoints should
be added to the model. In the final model, each join-
point indicates a statistically significant change, either
increase or decrease, in trend [23]. We selected the
Bayesian information criterion approach, which identi-
fies the model with the best fit by penalizing the cost of
extra parameters. The annual percentage change (APC)
is calculated for the time segments on either side of
inflection points. Joinpoint regression analyses were per-
formed using Joinpoint version 3.2 software obtained
from the US National Cancer Institute [23].
Results
Trends in total amenable mortality
Table 1 shows the results of the joinpoint analysis. For
all causes of deaths, the decline in the mortality rate
was significant before implementation of the NHI. It
became briefly insignificant (in both sexes combined
and males alone) and again significant immediately after
implementation of NHI, at a similar rate of decline to
before NHI.
Turning to amenable mortality for men and women
combined, the joinpoint analysis identified three signifi-
cant inflection points, generating four distinct trends
between 1981 and 2005. A steady decline from 1981
(APC = -4.38, p < .05) was arrested in 1993 (APC =
-0.53, p = .84) but then accelerated downward after
1996 (APC = -5.83, p < .05) before slowing once more
in 1999 (APC = -2.77, p < .05). When analyzed sepa-
rately, a similar trend was identified for women while
for men an additional inflection point was identified in
1987 (APC = -3.61, p < .05). Mortality from other
causes fell consistently for both sexes between 1981 and
1999 (APC = -0.64, p < .05), although at a somewhat
slower rate compared to amenable mortality; it acceler-
ated downward after 1999 (APC = -2.74, p < .05),
arrested in 2003 and thereafter (APC = 1.04, p = .65).
Similar trends were found in men but for women only
one inflection point was identified in 1989, following a
smaller decline in the previous period.
Table 1 further shows amenable mortality with 50% of
deaths from IHD included. For men and women com-
bined (and also for men alone), the pattern was similar
to that seen for amenable mortality without 50% IHD;
but for females, no inflection point was identified.
Further analysis using IHD deaths alone for men and
women combined reveals that a decelerating increase
between 1981 and 1992 (APC = -1.78, p < 0.05) was
reversed in 1992 (APC = -2.61, p < .05). Similar trends
were found in men but for women, an additional inflec-
tion point was identified in 1998 (APC = -2.66, p > .05),
following an accelerated downward trend after 1992
(APC = -6.73, p < .05).
Trends of amenable mortality by age
Tables 2 stratifies amenable mortality by age groups for
both sexes. It suggests that the effect of NHI implemen-
tation was more apparent among those under age 20.
A declining trend in amenable mortality briefly reversed
between 1992 or 1993 and 1996, followed by a signifi-
cant decrease thereafter (APC = -5.84). For those at
working age (20-64 years) there was no significant effect
of NHI except for the period 1999-2005. A similar pat-
tern was seen for those aged 65 and over, although the
magnitude of the decline in amenable mortality during
1999-2005 (APC = -2.91, p < .05) was higher than
among those of working age (APC = -1.21, p < .05).
Trends of amenable mortality by sub-group amenable
causes
Table 3 summarizes the analyses for major amenable
causes of death. For circulatory diseases, the picture was
similar to that for all amenable causes. On average, the
ASMR declined significantly (10.19%, 8.63% and 9.13%
per year) among women, men, and both combined
respectively, following the introduction of NHI (1996-
1999). These trends continued at a slower, but still sig-
nificant rate during 1999-2005. The ASMR for treatable
cancers increased significantly during 1990-97. Soon
after the introduction of NHI, the trends for women
(APC = -1.49, p < .05) and for both sexes together (APC
= -0.75, p < .05) began to reverse, significantly so, dur-
ing 1997-2005. The trend for men continued to
increase, although at a slower rate, becoming insignifi-
cant during 1997-2005. Trends in infectious diseases
showed no clear pattern except for a significant decline
after 1997 for men (APC = -10.03, p < .05). There was
no significant change in trends of respiratory disease
and genitourinary disease mortality that can be asso-
ciated with the introduction of NHI.
Figure 1 Trends in amenable and non-amenable mortality age
0-74 in Taiwan, 1981-2005.
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Discussion
In this study we assessed changes in amenable mortality
before and after implementation of universal health
insurance coverage in Taiwan. We find that the intro-
duction of NHI was associated with a significant accel-
eration in the rate of decline of causes of death
considered amenable to health care. In contrast, there
was no clear change in the trend of mortality from con-
ditions not considered amenable to health care that
could be associated with the introduction of NHI. These
findings are in general consistent with our hypothesis
and with studies reviewed by Levy and Meltzer which,
while noting methodological limitations, found that
improved health insurance coverage was associated with
improved health [2,3,24-27].
Our study also found that the association with the
introduction of NHI was more apparent among the
young, aged less than 20 years, followed by the elderly,
and least among the working age population. This result
is consistent with our expectations as 77% of the work-
ing age population were already covered by the pre-
existing social insurance; thus they were inevitably going
to be affected less by the introduction of NHI. In con-
trast, most children, except children of government
employees, were previously uninsured; only 14% of
those aged 20 had social insurance coverage and there-
fore had more to gain.
Our analysis did not find substantial benefits accruing
to elderly people but it must be recalled that amenable
deaths occur, by definition, below the age of 75 years.
This is for a number of reasons, including the problems
of coding often multiple co-existing causes contributing
to death, but it does constrain the power of our study to
identify a true effect. Furthermore, unlike with children,
Table 1 Joinpoint regression analyses on age-standardized amenable mortality rates in Taiwan, 1981-2005
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Mortality Time Period APC Time Period APC Time Period APC Time Period APC Time Period APC
All causes
Both genders 1981-1993 -1.74* 1993-1996 -0.57 1996-2003 -2.50* 2003-2005 0.06
Females 1981-1996 -2.22* 1996-2005 -2.72*
Males 1981-1984 -2.36* 1984-1993 -1.23* 1993-1996 -0.09 1996-2003 -2.25* 2003-2005 1.08
Amenable causes
Both genders 1981-1993 -4.38* 1993-1996 -0.53 1996-1999 -5.83* 1999-2005 -2.77*
Females 1981-1993 -4.45* 1993-1996 -1.48 1996-1999 -5.70* 1999-2005 -3.21*
Males 1981-1987 -5.05* 1987-1993 -3.61* 1993-1996 -0.53 1996-1999 -5.77* 1999-2005 -2.45*
Other causes (non-amenable causes)
Both genders 1981-1999 -0.64* 1999-2003 -2.74* 2003-2005 1.04
Females 1981-1989 -0.48 1989-2005 -1.80*
Males 1981-1999 -0.37* 1999-2003 -2.47* 2003-2005 1.72
Amenable causes with 50% IHD
Both genders 1981-1993 -4.04* 1993-1996 -0.81 1996-1999 -5.67* 1999-2005 -2.61*
Females 1981-2005 -3.86*
Males 1981-1987 -4.66* 1987-1993 -3.18* 1993-1996 -0.78 1996-1999 -5.50 1999-2005 -2.22*
IHD
Both genders 1981-1992 1.78* 1992-2005 -2.61*
Females 1981-1992 1.51 1992-1998 -6.73 1998-2005 -2.66
Males 1981-1992 2.29* 1992-2005 -1.63*
Note. APC= annual percent change; IHD= ischemic heart disease.
* APC is statistically significantly different from zero (2-sided at p < .05).
Table 2 Joinpoint regression analyses on amenable mortality rates by age-group in Taiwan, 1981-2005
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Age group Time Period APC Time Period APC Time Period APC Time Period APC Time Period APC
Under 20 years 1981-1987 -11.64* 1987-1993 -3.29* 1993-1996 12.36 1996-2005 -5.84*
20-64 years 1981-1987 -4.63* 1987-1996 -2.27* 1996-1999 -4.75 1999-2005 -1.21*
65 years and over 1981-1989 -4.06* 1989-1993 -6.33* 1993-1996 -1.31 1996-1999 -5.29 1999-2005 -2.91*
Note. APC= annual percent change.
* APC is statistically significantly different from zero (2-sided at p < .05).
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where coverage was very low, 57% of elderly people
were already covered by social insurance before the
introduction of NHI. In addition, elderly people in poor
health may have selectively enrolled in either the Indi-
gent Health Insurance or Farmers Health Insurance
(FHI) schemes introduced in 1989, or fraudulently used
vouchers of people with insurance coverage to visit a
doctor, something that was not uncommon in the pre-
vious system. Taken together, these factors may explain
the weak association between introduction of NHI and
health gain among the elderly. However, our finding
that the effect attributed to NHI varied among people
with different levels of social insurance coverage sup-
ports the view that the decline in amenable mortality
was related to introduction of NHI.
Our finding of a significant effect of NHI on popula-
tion health may seem to contradict previous studies in
Taiwan that were unable to demonstrate a significant
gain in life expectancy a decade after the introduction of
NHI [13] or significant changes in perceived health sta-
tus among the elderly [12]. However, the present study
uses a more specific measure of the contribution of
health care [15,17] whereas changes in life expectancy
and perceived health status are likely to reflect a broader
spectrum of health determinants including changes in
life style, environmental and biological factors. Further-
more, the application of joinpoint regression in this
study allows us to identify inflection points and relate
them to the introduction of NHI, something not possi-
ble with the earlier studies that simply compared before
and after findings.
Our study is also inconsistent with the Rand health
insurance study [28,29], a randomized controlled trial
which found health insurance coverage, with a few
exceptions, did not improve the health of adults. How-
ever, as Levy and Meltzer [2] have noted, it did not
include people who previously had no health insurance;
nor did it include elderly persons so the results are not
comparable.
The analysis by major causes of amenable death yields
results that are consistent with those found elsewhere
[19]. A more detailed analysis (data not shown) revealed
that the decline in circulatory diseases was largely due
to a reduction in cerebrovascular and hypertensive mor-
tality, which can plausibly be linked to a documented
significant improvement in hypertension control [28] as
well as, potentially, better quality of care in cerebrovas-
cular disease. The decline in female cancer mortality
can be attributed to a reduction in deaths from cervical
cancer, associated with increased use of Pap smear
screening [30,31], and improved outcomes with leuke-
mia. Our finding of a significant reduction in male
infectious disease mortality (-10.03% during 1997-2005)
was due to a substantial decline in mortality from tuber-
culosis and septicemia in Taiwan during the study
period (data not shown).
Table 3 Joinpoint regression analyses on sub-group age-standardized amenable mortality rates in Taiwan, 1981-2005
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Diseases Time Period APC Time Period APC Time Period APC Time Period APC Time Period APC
Circulatorya 1981-1984 -3.25* 1984-1993 -6.35* 1993-1996 -3.80 1996-1999 -9.13* 1999-2005 -4.12*
Females 1981-1988 -5.11* 1988-1993 -8.53* 1993-1996 -5.40 1996-1999 -10.19* 1999-2005 -5.51*
Males 1981-1983 -1.13 1983-1993 -5.75* 1993-1996 -1.91 1996-1999 -8.63* 1999-2005 -3.33*
Infectionsb 1981-1986 -9.05* 1986-1989 2.62 1989-1993 -5.47* 1993-2005 -9.65*
Females 1981-1985 -8.78* 1985-1992 -0.99 1992-2005 -10.82*
Males 1981-1986 -9.37* 1986-1989 2.95 1989-1997 -7.10* 1997-2005 -10.03*
Cancerc 1981-1991 0.29 1991-1997 2.96* 1997-2005 -0.75*
Females 1981-1990 0.63* 1990-1997 2.11* 1997-2005 -1.49*
Males 1981-1991 -0.73 1991-1997 4.56* 1997-2005 0.77
Respiratoryd 1981-1984 -16.06* 1984-1990 4.43 1990-1993 -12.52 1993-2005 -0.09
Females 1981-1984 -17.45* 1984-1990 2.34 1990-1994 -12.80 1994-2005 -1.04
Males 1981-1983 -22.29 1983-1990 4.13 1990-1993 -10.16 1993-2005 0.53
Genitourinarye 1981-1989 -5.61* 1989-1995 1.96 1995-1999 -4.75 1999-2002 3.36 2002-2005 -2.83
Females 1981-1988 -5.78* 1988-2005 -1.13*
Males 1981-1989 -5.47* 1989-1995 3.13* 1995-1999 -4.23 1999-2005 0.84
Note. APC= annual percent change.
a include chronic rheumatic heart disease, hypertensive disease, and cerebrovascular disease
b include intestinal infections, tuberculosis, other infections (diphtheria, tetanus, poliomyelitis), whooping cough, septicemia, and measles
c include colon and rectum, skin, breast, cervix uteri, cervix uteri and body of uterus, testis, Hodgkin’s disease, and leukemia
d include all respiratory diseases, influenza, and pneumonia
e include nephritis and nephrosis, and benign prostatic hyperplasia
* APC is statistically significantly different from zero (2-sided at p < .05).
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It is necessary to discuss what may seem like an
inconsistency, whereby the causes of death making the
greatest contribution to the overall decline in amenable
mortality are rare in young people, who exhibit the
greatest falls in amenable deaths. This is because the
underlying death rate is low at young age groups, so
reductions in amenable mortality from causes dominat-
ing here (that are less common at older ages) will have
little impact on total amenable mortality. In contrast, a
smaller reduction at older ages, where overall death
rates are much higher, will allow those causes of death
common in this age group to dominate amenable mor-
tality overall.
Our study design, a large-scale (23 million population)
national natural experiment using a joinpoint method,
while observational in nature, allows us to compare
changes in amenable mortality across different periods
in time with mortality not considered amenable to
health care and among different age groups with differ-
ent health insurance coverage. However, the design,
does not allow us to rule out all alternative explanations,
and prevents us drawing causal inference, a problem
identified by Levy and Meltzer in all observational stu-
dies [2]. Besides, we were not able, in this analysis, to
assess the health impact of expansion of insurance cov-
erage at the individual level. The aggregate change,
which includes the 60% who already had coverage
before the introduction of NHI, will therefore underesti-
mate the impact on the previously uninsured. An earlier
study did, however, find that overall life expectancy,
with all its limitations as a measure of health system
performance, improved more in the poorest in Taiwa-
nese society after introduction on NHI [13].
It is difficult to explain the levelling out in the decline
in amenable mortality in 1993 to 1996. Some tentative
explanations can, however, be advanced. First, the rate
of expansion of insurance coverage had been slowing
between 1987 and 1994. Second, it took some time for
the NHI to become established. It was launched in
March 1995, three months into the year and unem-
ployed people could delay enrollment for the first year.
Third, it took some time for the health care delivery sys-
tem to respond to the new financing model; for exam-
ple, adult preventive services were not launched until
April 2006. Finally, the NHI paid little attention to
access by people living in remote areas until 1996. How-
ever, it may simply be that the major organizational
changes involved in implementing NHI caused those
working in the health care delivery system to be dis-
tracted from their core activities. This would be consis-
tent with research on other forms of organizational
change, such as hospital mergers, where the process of
reorganization can lead to a loss of managerial focus
and reduction in quality of care that can last for several
years [32,33]. This is, however, a finding that requires
further exploration.
Looking ahead, while the Taiwanese NHI has suc-
ceeded in terms of cost (3.4% of GDP), satisfaction
(77.5% satisfied in 2007), low administrative cost
(1.49%), and equitable financial burden [8,9], the system
is not without problems. For example, as a publicly-
managed program, it is difficult to insulate it from
political interference, a factor that has contributed to a
continuing financial deficit. Thus, the existing budget
may be inadequate to sustain the current level of perfor-
mance [34].
Limitations
Our study also suffers from some limitations. First,
reductions in amenable mortality may reflect a combina-
tion of three factors. These are improved access to care
(for example through expansion of coverage), improved
quality, and therapeutic innovation. As we have argued,
it is plausible, given the timings of the changes observed,
that the first of these has been important but we cannot
exclude a contribution from the second and third. The
only relevant data we have been able to find relate to
case fatality from myocardial infarction, which improved
steadily from 1996 onwards [35], but we are unable to
ascertain whether this was a deviation of earlier trends.
Second, as with most research on the contribution of
health care to population health, by omitting potentially
important factors that might reduce the underlying inci-
dence of treatable diseases and thus the burden on the
health care system. These include improvements in edu-
cation, nutrition, and exposure to risk factors such as
tobacco and alcohol. We were also unable to take
account of possible changes in the delivery of health
care or the ability to pay for care outside the NHI
scheme.
Third, there are likely to be variable lag periods
between expansion of coverage and reduction in amen-
able mortality. For example, the immediate treatment of
a myocardial infarction (e.g. thrombolysis) may have an
impact at once while treatment with statins or anti-
hypertensives will reduce risk after a longer (and vari-
able) period. The consequences will be to dilute any
effect of the introduction of NHI.
Thus, our results must be interpreted with some
caution.
Policy Implications
These findings have implications for other countries that
do not have universal health insurance coverage. The
implementation of NHI in Taiwan was associated with a
sustained reduction in deaths from causes amenable to
health care, which surpassed the underlying decline in
other causes. It is reasonable to expect that the
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introduction of universal coverage elsewhere might also
have beneficial effects [19].
Conclusions
Our study found that the expansion of health insurance
coverage by Taiwan’s NHI may have achieved one of its
goals, to improve the health of the nation’s population.
The effect was most apparent among the age groups
who were previously least likely to be insured. The
major contribution to declining amenable mortality was
the reduction in deaths from circulatory diseases, male
infectious diseases and female treatable cancers. Our
study takes advantage of a large scale natural experi-
ment and uses the joinpoint method, to evaluate the
impact of introducing NHI on population health. There
are, however, some caveats. The design is not strong
enough to rule out all alternative explanations than
NHI. Besides, the observed gains are likely to be greater
among those previously uninsured and we may have
underestimated the scale of improvement because of
coincident changes to recording of infant deaths.
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